Schmidt-Erfurth U - Search Results

1

TOPOGRAPHIC ANALYSIS OF PHOTORECEPTOR LOSS CORRELATED WITH DISEASE MORPHOLOGY IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION.

Riedl S, Cooney L, Grechenig C, Sadeghipour A, Pablik E, Seaman JW 3rd, Waldstein SM, Schmidt-Erfurth U. Riedl S, et al. Retina. 2020 Nov;40(11):2148-2157. doi: 10.1097/IAE.0000000000002717. Retina. 2020. PMID: 31842189 Clinical Trial.

2

Macular injury by a military range finder.

Roider J, Buesgen P, Hoerauf H, Schmidt-Erfurth U, Laqua H, Birngruber R. Roider J, et al. Retina. 1999;19(6):531-5. doi: 10.1097/00006982-199911000-00009. Retina. 1999. PMID: 10606454

3

Scotoma size and reading speed in patients with subfoveal occult choroidal neovascularization in age-related macular degeneration.

Ergun E, Maár N, Radner W, Barbazetto I, Schmidt-Erfurth U, Stur M. Ergun E, et al. Ophthalmology. 2003 Jan;110(1):65-9. doi: 10.1016/s0161-6420(02)01566-x. Ophthalmology. 2003. PMID: 12511348 Clinical Trial.

4

Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: meta-analysis of 2-year safety results in three randomized clinical trials: Treatment Of Age-Related Macular Degeneration With Photodynamic Therapy and Verteporfin In Photodynamic Therapy Study Report no. 4.

Azab M, Benchaboune M, Blinder KJ, Bressler NM, Bressler SB, Gragoudas ES, Fish GE, Hao Y, Haynes L, Lim JI, Menchini U, Miller JW, Mones J, Potter MJ, Reaves A, Rosenfeld PJ, Strong A, Su XY, Slakter JS, Schmidt-Erfurth U, Sorenson JA; Treatment of Age-Related Macular Degeneration with Photodynamic Therapy (TAP) Study Group; Verteporfin in Photodynamic Therapy (VIP) Study Group. Azab M, et al. Retina. 2004 Feb;24(1):1-12. doi: 10.1097/00006982-200402000-00001. Retina. 2004. PMID: 15076937

5

Comparison of the original Amsler grid with the modified Amsler grid: result for patients with age-related macular degeneration.

Augustin AJ, Offermann I, Lutz J, Schmidt-Erfurth U, Tornambe P. Augustin AJ, et al. Retina. 2005 Jun;25(4):443-5. doi: 10.1097/00006982-200506000-00008. Retina. 2005. PMID: 15933590

6

Anecortave acetate for the treatment of subfoveal choroidal neovascularization secondary to age-related macular degeneration.

Schmidt-Erfurth U, Michels S, Michels R, Aue A. Schmidt-Erfurth U, et al. Eur J Ophthalmol. 2005 Jul-Aug;15(4):482-5. doi: 10.1177/112067210501500411. Eur J Ophthalmol. 2005. PMID: 16001382 Clinical Trial.

7

Verteporfin therapy for choroidal hemangioma: a long-term follow-up.

Michels S, Michels R, Simader C, Schmidt-Erfurth U. Michels S, et al. Retina. 2005 Sep;25(6):697-703. doi: 10.1097/00006982-200509000-00003. Retina. 2005. PMID: 16141856

8

Comparison of early retreatment with the standard regimen in verteporfin therapy of neovascular age-related macular degeneration.

Michels S, Wachtlin J, Gamulescu MA, Heimann H, Prünte C, Inhoffen W, Krebs I, Schmidt-Erfurth U. Michels S, et al. Ophthalmology. 2005 Dec;112(12):2070-5. doi: 10.1016/j.ophtha.2005.06.034. Epub 2005 Oct 12. Ophthalmology. 2005. PMID: 16225928 Clinical Trial.

9

Time course and morphology of vascular effects associated with photodynamic therapy.

Schmidt-Erfurth U, Niemeyer M, Geitzenauer W, Michels S. Schmidt-Erfurth U, et al. Ophthalmology. 2005 Dec;112(12):2061-9. doi: 10.1016/j.ophtha.2005.09.007. Ophthalmology. 2005. PMID: 16325705

10

Topographic angiography and optical coherence tomography: a correlation of imaging characteristics.

Ahlers C, Michels S, Elsner H, Birngruber R, Pruente C, Schmidt-Erfurth U. Ahlers C, et al. Eur J Ophthalmol. 2005 Nov-Dec;15(6):774-81. doi: 10.1177/112067210501500619. Eur J Ophthalmol. 2005. PMID: 16329065

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

617 results

Search Page

Filters